Treatment of pseudomonas and Staphylococcus bronchopulmonary infection in patients with cystic fibrosis.
about
Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its SymptomsCiprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureusPharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence.
P2860
Treatment of pseudomonas and Staphylococcus bronchopulmonary infection in patients with cystic fibrosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Treatment of pseudomonas and S ...... patients with cystic fibrosis.
@en
Treatment of pseudomonas and S ...... patients with cystic fibrosis.
@nl
type
label
Treatment of pseudomonas and S ...... patients with cystic fibrosis.
@en
Treatment of pseudomonas and S ...... patients with cystic fibrosis.
@nl
prefLabel
Treatment of pseudomonas and S ...... patients with cystic fibrosis.
@en
Treatment of pseudomonas and S ...... patients with cystic fibrosis.
@nl
P2093
P2860
P31
P356
P1476
Treatment of pseudomonas and S ...... patients with cystic fibrosis.
@en
P2093
Meenu Singh
Rashmi Ranjan Das
Sushil Kumar Kabra
P2860
P304
P356
10.1155/2013/645653
P407
P5008
P577
2013-12-30T00:00:00Z